Contact
![Contact Meredith Alda](https://cdn.statcdn.com/contactPerson/3646.jpg)
Mon - Fri, 9am - 6pm (EST)
![Contact Yolanda Mega](https://cdn.statcdn.com/contactPerson/3195.jpg)
Mon - Fri, 9am - 5pm (SGT)
![Contact Kisara Mizuno](https://cdn.statcdn.com/contactPerson/2661.jpg)
Mon - Fri, 10:00am - 6:00pm (JST)
![Contact Lodovica Biagi](https://cdn.statcdn.com/contactPerson/863.jpg)
Mon - Fri, 9:30am - 5pm (GMT)
![Contact Carolina Dulin](https://cdn.statcdn.com/contactPerson/3012.jpg)
Mon - Fri, 9am - 6pm (EST)
Key regions: Germany, Italy, France, Japan, United Kingdom
The Ophthalmic Devices market in EU-27 is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and macroeconomic factors are all contributing to this growth. Customer preferences in the Ophthalmic Devices market in EU-27 are driving the demand for innovative and technologically advanced products. Customers are increasingly seeking devices that offer improved accuracy, precision, and comfort. They are also looking for products that are easy to use and maintain. As a result, manufacturers are investing in research and development to meet these customer preferences and stay competitive in the market. Trends in the market are also influencing the growth of the Ophthalmic Devices market in EU-27. One major trend is the increasing prevalence of eye diseases and disorders, such as cataracts, glaucoma, and age-related macular degeneration. This is driving the demand for diagnostic and surgical devices that can effectively diagnose and treat these conditions. Another trend is the rise in the elderly population in EU-27, which is more prone to eye diseases and requires regular eye examinations and treatments. Local special circumstances in EU-27 are also contributing to the growth of the Ophthalmic Devices market. EU-27 countries have well-established healthcare systems that provide access to quality eye care services. This, coupled with increasing awareness about eye health and the importance of regular eye examinations, is driving the demand for ophthalmic devices. Additionally, EU-27 countries have a high level of healthcare expenditure, which allows for the adoption of advanced technologies and treatments in the field of ophthalmology. Underlying macroeconomic factors are also playing a role in the development of the Ophthalmic Devices market in EU-27. The growing economy in EU-27 countries is leading to increased disposable income, which allows individuals to afford expensive ophthalmic devices and treatments. Moreover, advancements in healthcare infrastructure and favorable reimbursement policies are facilitating the adoption of ophthalmic devices. In conclusion, the Ophthalmic Devices market in EU-27 is experiencing growth and development due to customer preferences, market trends, local special circumstances, and macroeconomic factors. The demand for innovative and technologically advanced devices, the increasing prevalence of eye diseases, the rise in the elderly population, well-established healthcare systems, high healthcare expenditure, and growing economy are all contributing to this growth. As the market continues to evolve, manufacturers will need to stay ahead of customer preferences and market trends to remain competitive in the Ophthalmic Devices market in EU-27.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)